论文部分内容阅读
以环子孢子(CS)蛋白表位为基础的子孢子疫苗的临床试验结果不佳,疟疾流行区人群只产生弱的抗子孢子免疫力,其中能对整个CS蛋白序列400个残基中一种多肽产
Results of clinical trials of sporozoite vaccine based on the epitope of the sporozoite protein (CS) have not been well established. The population in the endemic areas of malaria only produced weak anti-sporozoite immunity, of which one of the 400 residues in the entire CS protein sequence Polypeptide production